Results comparison of fluorescence PCR melting curve method and GeneXpert MTB/RIF technology on detecting Mycobacterium tuberculosis complex and rifampicin resistance
-
摘要: 目的 比较荧光熔解曲线法和GeneXpert MTB/RIF技术对不同类型样本结核分枝杆菌复合群和利福平耐药性的检测结果,旨在为临床不同类型样本如何选择试验方法提供参考,以提高检出率。方法 收集2019年8月—2020年7月收治的疑似和确诊结核病患者的临床资料和实验室数据,回顾性分析荧光熔解曲线法和GeneXpert MTB/RIF技术检测结核分枝杆菌复合群和利福平耐药情况。结果 荧光熔解曲线法共检测样本937例,检出结核分枝杆菌复合群282例,阳性率30.10%(282/937);其中呼吸道样本、术后标本阳性率分别为29.07%(252/867)、57.69%(30/52),其他类型样本未检测出阳性。GeneXpert MTB/RIF共检测样本3807例,检出结核分枝杆菌复合群1315例,阳性率34.54%(1315/3807);其中呼吸道样本、术后标本、胸水、腹水、脑脊液、其他体液、24 h尿沉渣以及粪阳性率分别为36.05%(1099/2799)、75.09%(202/269)、14.34%(71/495)、9.62%(5/52)、10.87%(15/138)、22.22%(4/18)、29.63%(8/27)和11.11%(1/9)。GeneXpert MTB/RIF技术检测结核分枝杆菌复合群的阳性率明显高于荧光熔解曲线法(χ2=6.655,P=0.010),其中,呼吸道样本、术后标本的检出率明显高于其他样本类型(χ2=29.584,P< 0.01;χ2=6.584,P=0.017)。133例患者同时进行了荧光熔解曲线法、GeneXpert MTB/RIF技术和结核菌培养及表型药敏试验,结果表明表型药敏检测利福平敏感率为68.42%(91/133)、利福平耐药率为31.58%(42/133);荧光熔解曲线法检测结果为利福平敏感率为63.91%(85/133)、利福平耐药率为30.83%(41/133);GeneXpert MTB/RIF技术检测结果为利福平敏感率为66.92%(89/133)、利福平耐药率为31.58%(42/133);2种分子药敏检测结果与表型药敏检测结果比较,差异无统计学意义(P>0.05)。结论 GeneXpert MTB/RIF技术对于临床不同类型的样本结核分枝杆菌复合群的检出率明显优于荧光熔解曲线法,但2种方法检测利福平耐药得到的结果与表型药敏无差异。特别是GeneXpert MTB/RIF技术,因其操作高度自动化,对结核分枝杆菌复合群的检出率较高,更加适合结核患者病原学快速诊断的需求。
-
关键词:
- 荧光熔解曲线法 /
- GeneXpert MTB/RIF技术 /
- 结核分枝杆菌符合群 /
- 利福平 /
- 耐药
Abstract: Objective To provide references for options of clinical detection methods in different samples by comparing the results of fluorescence PCR melting curve and GeneXpert MTB/RIF on detecting Mycobacterium tuberculosis complex(MTC) and rifampicin resistance, so as to improve the detection rate of tuberculosis.Methods Clinical and laboratory data of suspected and confirmed tuberculosis patients admitted to our hospital from August 2019 to July 2020 were collectde, and the detection results of MTC and rifampicin resistance which detected by fluorescence melting curve and GeneXpert MTB/RIF were retrospectively analyzed.Results A total of 937 samples were detected by the fluorescence melting curve, and 282 cases of MTC were detected with a positive rate of 30.10%(282/937), of which the positive rates of samples in the respiratory tract and postoperative samples were 29.07%(252/867) and 57.69%(30/52), respectively. There was no positive result in other samples. A total of 3807 samples were detected by GeneXpert MTB/RIF, and 1315 cases of MTC were detected with a positive rate of 34.54%(1315/3807). The positive rates of samples in the respiratory tract, postoperative specimens, pleural fluid, ascites, cerebrospinal fluid, other body fluids, 24-hour urine sediment, and feces were 36.05%(1099/2799), 75.09%(202/269), 14.34%(71/495), 9.62%(5/52), 10.87%(15/138), 22.22%(4/18), 29.63%(8/27) and 11.11%(1/9), respectively. The positive rate of GeneXpert MTB/RIF in detecting MTC was significantly higher than that of fluorescent PCR melting curve(χ2=6.655,P=0.010). Among them, the detection rate of samples in the respiratory tract and postoperative specimens was significantly higher than that of other samples(χ2=29.584,P< 0.01;χ2=6.584,P=0.017). A total of 133 patients were simultaneously detected by fluorescence melting curve, GeneXpert MTB/RIF and tuberculosis culture and phenotypic drug sensitivity test. The results showed that the rate of rifampin sensitivity was 68.42%(91/133) and the rate of rifampicin resistance was 31.58%(42/133) in the phenotypic drug sensitivity test, and the rate of rifampicin sensitivity was 63.91%(85/133) and the rate of rifampicin resistance was 30.83%(41/133) in fluorescence melting curve. And the results showed that the rate of rifampicin sensitivity was 66.92%(89/133) and the rate of rifampicin resistance 31.58%(42/133) in GeneXpert MTB/RIF. The results between the two molecular drug sensitivity tests and the phenotypic drug sensitivity test had no statistical difference(P>0.05).Conclusion The detection rate of GeneXpert MTB/RIF for different types of clinical samples of MTC is significantly higher than the fluorescence melting curve, and there is no difference between the results obtained by the two molecular methods for detecting rifampicin resistance and the phenotypic drug sensitivity. Particularly, because of the highly automated operation of the GeneXpert MTB/RIF and its higher detection rate of MTC, it may be more suitable for the need of rapid pathogenic diagnosis in tuberculosis patients. -
表 1 2种检测方法检出结核分枝杆菌复合群的阳性率
样本类型 荧光熔解曲线法 GeneXpert MTB/RIF技术 检测数 阳性数 阳性率/% 检测数 阳性数 阳性率/% 呼吸道样本 867 252 29.07 2799 1099 36.05 术后标本 52 30 57.69 269 202 75.09 胸水 10 0 / 495 71 14.34 腹水 4 0 / 52 5 9.62 脑脊液 3 0 / 138 15 10.87 其他体液 / / / 18 4 22.22 尿 1 0 / 27 8 29.63 粪 / / / 9 1 11.11 合计 937 282 30.1 3807 1315 34.54 吸道样本包括痰及肺泡灌洗液;术后标本(包括肺组织、淋巴结、脓液、分泌物等);其他体液包括关节腔液、胸腔积液、腹腔积液、心包积液、引流液。 -
[1] 余传星, 张焕, 黄明翔, 等. 快速鉴定结核杆菌的双重分子信标检测体系的优化[J]. 国际检验医学杂志, 2018, 39(9): 1029-1033. doi: 10.3969/j.issn.1673-4130.2018.09.002
[2] Morel F, Jaffré J, Sougakoff W, et al. [Molecular diagnosis of tuberculosis][J]. Rev Mal Respir, 2020, 37(5): 412-416. doi: 10.1016/j.rmr.2019.09.004
[3] 李爱芳, 崔晓利, 康磊, 等. 荧光PCR探针熔解曲线法检测结核分枝杆菌耐药性的价值[J]. 中国防痨杂志, 2020, 42(9): 998-1002. doi: 10.3969/j.issn.1000-6621.2020.09.022
[4] 冯秀莉, 任欣欣, 刘朋冲, 等. X-pert、SAT和LAMP诊断肺结核的价值对比[J]. 现代科学仪器, 2020, 12(3): 96-100.
[5] 陈军, 陈丽峰, 饶有益, 等. GeneXpert MTB/RIF试验与4种结核分枝杆菌检测方法的比较[J]. 临床血液学杂志, 2018, 31(12): 956-959. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXZ201812019.htm
[6] 国家卫生和计划生育委员会中华人民共和国农业部国家食品药品监督管理总局公告2016年第16号[J]. 农产品质量与安全, 2017, (2): 92-94. https://www.cnki.com.cn/Article/CJFDTOTAL-NYZL201702023.htm
[7] Acharya B, Acharya A, Gautam S, et al. Advances in diagnosis of Tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis[J]. Mol Biol Rep, 2020, 47(5): 4065-4075. doi: 10.1007/s11033-020-05413-7
[8] Sasikumar C, Utpat K, Desai U, et al. Role of GeneXpert in the diagnosis of mycobacterium tuberculosis[J]. Adv Respir Med, 2020, 88(3): 183-188. doi: 10.5603/ARM.2020.0102
[9] Terzi HA, Aydemir O, Karakece E, et al. Comparison of the GeneXpert® MTB/RIF Test and Conventional Methodsin the Diagnosis of Mycobacterium tuberculosis[J]. Clin Lab, 2019, 65(1).
[10] 张鸿娟, 宋宇, 郭翀, 等. 实时荧光PCR检测结核杆菌DNA的分析灵敏度验证及临床应用[J]. 检验医学与临床, 2017, 14(11): 1528-1530. doi: 10.3969/j.issn.1672-9455.2017.11.003
[11] 唐桂华, 孙倩, 王潇凡, 等. GeneXpert MTB/RIF技术对结核病及对利福平耐药性检测的价值[J]. 结核病与肺部健康杂志, 2020, 1(3): 121-125. https://www.cnki.com.cn/Article/CJFDTOTAL-FBJK202003007.htm